The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Six Brokers Cut Tate & Lyle Price Target

Fri, 14th Feb 2014 10:10

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning:
----------
FTSE 100
----------
JPMORGAN RAISES LLOYDS TO 'OVERWEIGHT' ('NEUTRAL') - TARGET 95 (84) PENCE
----------
SOCGEN RAISES LLOYDS PRICE TARGET TO 94 (86) PENCE - 'BUY'
----------
BERENBERG RAISES PETROFAC TO 'BUY' ('HOLD') - TARGET 1740 (1370) PENCE
----------
BARCLAYS RAISES GLAXOSMITHKLINE PRICE TARGET TO 1575 (1545) PENCE - 'EQUAL WEIGHT'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1800 (1750) PENCE - 'HOLD'
----------
EXANE BNP CUTS MORRISON TO 'UNDERPERFORM' ('NEUTRAL') - TARGET 200 (230) PENCE
----------
SOCGEN RAISES ROLLS-ROYCE TO 'HOLD' ('SELL') - TARGET 1070 (1150) PENCE
----------
LIBERUM CUTS ROLLS-ROYCE PRICE TARGET TO 1300 (1340) PENCE - 'BUY'
----------
JPMORGAN CUTS TATE & LYLE PRICE TARGET TO 825 (900) PENCE - 'OVERWEIGHT'
----------
CITIGROUP CUTS TATE & LYLE PRICE TARGET TO 800 (900) PENCE - 'BUY'
----------
DEUTSCHE BANK CUTS TATE & LYLE PRICE TARGET TO 900 (1030) PENCE - 'BUY'
----------
CREDIT SUISSE CUTS TATE & LYLE PRICE TARGET TO 700 (800) PENCE - 'NEUTRAL'
----------
PANMURE CUTS TATE & LYLE PRICE TARGET TO 680 (750) PENCE - 'HOLD'
----------
MORGAN STANLEY CUTS TATE & LYLE PRICE TARGET TO 700 (880) PENCE - 'EQUAL-WEIGHT'
----------
CITIGROUP RAISES RIO TINTO PRICE TARGET TO 4200 (4000) PENCE - 'BUY'
----------
JPMORGAN RAISES RIO TINTO PRICE TARGET TO 4600 (4500) PENCE - 'OVERWEIGHT'
----------
MERRILL LYNCH CUTS RIO TINTO TO 'NEUTRAL' ('BUY') - PRICE TARGET 3800 (4200) PENCE
----------
EXANE BNP CUTS RECKITT BENCKISER PRICE TARGET TO 4400 (4600) PENCE - 'UNDERPERFORM,'
----------
SOCGEN RAISES SHIRE PRICE TARGET TO 3870 (3615) PENCE - 'BUY'
----------
CREDIT SUISSE RAISES SHIRE PRICE TARGET TO 3400 (3200) PENCE - 'NEUTRAL'
----------
CREDIT SUISSE CUTS BARCLAYS PRICE TARGET TO 260 (270) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES AGGREKO PRICE TARGET TO 1300 (1250) PENCE - 'UNDERWEIGHT'
----------
MORGAN STANLEY RAISES BABCOCK INTERNATIONAL PT TO 1550 (1450) PENCE - 'OVERWEIGHT.'
----------
MORGAN STANLEY RAISES BRITISH LAND PRICE TARGET TO 750 (690) PENCE - 'OVERWEIGHT.'
----------
MORGAN STANLEY RAISES HAMMERSON PT TO 560 (540) PENCE - 'EQUAL-WEIGHT'
----------
MORGAN STANLEY RAISES LAND SECURITIES PT TO 1120 (1040) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS INTERTEK PRICE TARGET TO 3300 (3750) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
UBS RAISES LADBROKES TO 'BUY' ('NEUTRAL') - TARGET 180 PENCE
----------
JPMORGAN RAISES ENTERTAINMENT ONE PRICE TARGET TO 356 (280) PENCE - 'OVERWEIGHT.'
----------
JPMORGAN RAISES MORGAN ADVANCED MATERIALS PRICE TARGET TO 350 (330) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS OPHIR ENERGY PRICE TARGET TO 400 (440) PENCE - 'OVERWEIGHT'
----------
MERRILL LYNCH CUTS TELECITY GROUP PRICE TARGET TO 595 (650) PENCE - 'UNDERPERFORM'
----------
UBS CUTS TELECITY GROUP PRICE TARGET TO 825 (950) PENCE - 'BUY'
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 1750 (1850) PENCE - 'BUY'
----------
UBS CUTS SERCO PRICE TARGET TO 400 (505) PENCE - 'NEUTRAL'
----------
UBS RAISES BELLWAY PRICE TARGET TO 1930 (1875) PENCE - 'BUY'
----------
PANMURE RAISES BELLWAY PRICE TARGET TO 1639 (1520) PENCE - 'BUY'
----------
DEUTSCHE BANK RAISES LANCASHIRE HOLDINGS PRICE TARGET TO 826 (822) PENCE - 'HOLD'
----------
PANMURE RAISES HIKMA PHARMACEUTICALS PRICE TARGET TO 1375 (1350) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES CARILLION PRICE TARGET TO 325 (315) PENCE - EQUAL-WEIGHT
----------
MORGAN STANLEY RAISES CAPITA GROUP PRICE TARGET TO 1050 (1000) PENCE - 'EQUAL-WEIGHT'
----------
PANMURE CUTS PZ CUSSONS PRICE TARGET TO 430 (445) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES DERWENT LONDON PRICE TARGET TO 3100 (2900) PENCE - OVERWEIGHT.
----------
MORGAN STANLEY RAISES GREAT PORTLAND PRICE TARGET TO 730 (680) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY RAISES INTU PROPERTIES PRICE TARGET TO 310 (300) PENCE - 'UNDERWEIGHT'
----------
MORGAN STANLEY RAISES LONDONMETRIC PROPERTY PRICE TARGET TO 135 (127) PENCE - 'UNDERW.'
----------
MORGAN STANLEY RAISES SEGRO PLC PRICE TARGET TO 380 (345) PENCE - 'OVERWEIGHT'
----------
MORGAN STANLEY CUTS SHAFTESBURY PRICE TARGET TO 660 (680) PENCE - 'EQUAL-WEIGHT.'
----------
NUMIS RAISES DE LA RUE TO 'ADD' ('HOLD') - TARGET 854 PENCE
----------
ALL-SHARE AND AIM
----------
MORGAN STANLEY CUTS APR ENERGY PRICE TARGET TO 1350 (1400) PENCE - 'OVERWEIGHT'
----------
PANMURE CUTS PHOENIX IT PRICE TARGET TO 138 (141) PENCE - 'HOLD'
----------
Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.